Medicamen Biotech Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 56.41 | 44.03 | 42.60 |
| Operating Expense | 50.55 | 38.41 | 37.18 |
| Net Profit | 2.97 | 2.59 | 2.21 |
| Net Profit Margin | 5.27% | 5.88% | 5.19% |
| Earning Per Share | 2.19 | 1.91 | 1.63 |
| EBIDTA | 5.95 | 5.76 | 5.54 |
| Effective Tax Rate | 11.11% | 11.41% | 12.55% |
Particulars
Mar 2026
Revenue56.41
Operating Expense50.55
Net Profit2.97
Net Profit Margin5.27
Earning Per Share2.19
EBIDTA5.95
Effective Tax Rate11.11
